I have to agree with you there. I'm holding long-term myself and do not have the time to trade for small gains. I consider myself as a long-term, value investor. Sure, I would not hold a penny stock for the long-term as far as risk is concerned. I believe Elite's ART would take the company far and would be the "next big thing" in the pharmaceuticals industry. I have total confidence in management and trust the decisions they have made thus far. When management announce that Naltrexone will be release soon, then there is no reason to second guess. The company is diligently working to get the drug out as soon as possible. The PRs may not excite the PPS but if it is good news, then it would get the company closer to its goals of profitability and stable growth to attract the "big investors". With our recently awarded patents, it is safe to assume that we are on their watchlist. Cheers!
Market Data 
Markets 
AI
